Cargando…
Personalized Decision Making on Genomic Testing in Early Breast Cancer: Expanding the MINDACT Trial with Decision-Analytic Modeling
BACKGROUND: Genomic tests may improve upon clinical risk estimation with traditional prognostic factors. We aimed to explore how evidence on the prognostic strength of a genomic signature (clinical validity) can contribute to individualized decision making on starting chemotherapy for women with bre...
Autores principales: | Steyerberg, Ewout W., de Wreede, Liesbeth C., van Klaveren, David, Bossuyt, Patrick M. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985855/ https://www.ncbi.nlm.nih.gov/pubmed/33655778 http://dx.doi.org/10.1177/0272989X21991173 |
Ejemplares similares
-
Shared decision making of burdensome surveillance tests using personalized schedules and their burden and benefit
por: Tomer, Anirudh, et al.
Publicado: (2022) -
Personalized Decision Making for Biopsies in Prostate Cancer Active Surveillance Programs
por: Tomer, Anirudh, et al.
Publicado: (2019) -
Personalized Prehospital Triage in Acute Ischemic Stroke: A Decision-Analytic Model
por: Venema, Esmee, et al.
Publicado: (2019) -
Business analytics for decision making
por: Kimbrough, Steven Orla, et al.
Publicado: (2018) -
Controlling technical variation amongst 6693 patient microarrays of the randomized MINDACT trial
por: Jacob, Laurent, et al.
Publicado: (2020)